Citius Oncology (CTOR)

• Market cap: $95.8M
• 1 day: 0%
• 5 days: 2.73%
• 1 month: -15.67%
• 3 months: -40.84%
• 6 months: -23.13%
• Year to date: -5.04%
• 1 year: 5.61%
• 5 years: -88.8%
• 10 years: -88.8%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.